CytoMed Therapeutics
GDTC
#9837
Rank
โ‚ฌ25.05 M
Marketcap
2,17ย โ‚ฌ
Share price
-4.03%
Change (1 day)
14.77%
Change (1 year)

EPS for CytoMed Therapeutics (GDTC)

EPS in 2021: -0,13ย โ‚ฌ

According to CytoMed Therapeutics's latest financial reports the company's current EPS (TTM) is -0,13ย โ‚ฌ. In 2021 the company made an earnings per share (EPS) of -0,13ย โ‚ฌ a decrease over its 2020 EPS that were of -0,12ย โ‚ฌ.

EPS history for CytoMed Therapeutics from 2020 to 2021

Annual EPS

Year EPS Change
2021-0,13ย โ‚ฌ3.73%
2020-0,12ย โ‚ฌ